Oncotarget

Research Papers:

Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase

Fei Xiao, Chunxia Wang, Hongkun Yin, Junjie Yu, Shanghai Chen, Jing Fang and Feifan Guo _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:63679-63689. https://doi.org/10.18632/oncotarget.11626

Metrics: PDF 2775 views  |   HTML 3527 views  |   ?  


Abstract

Fei Xiao1, Chunxia Wang1, Hongkun Yin1, Junjie Yu1, Shanghai Chen1, Jing Fang1, Feifan Guo1

1Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, The Graduate School of The Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, China

Correspondence to:

Feifan Guo, email: [email protected]

Keywords: leucine deprivation, breast cancer, proliferation, apoptosis

Received: October 27, 2015     Accepted: August 08, 2016     Published: August 26, 2016

ABSTRACT

Substantial studies on fatty acid synthase (FASN) have focused on its role in regulating lipid metabolism and researchers have a great interest in treating cancer with dietary manipulation of amino acids. In the current study, we found that leucine deprivation caused the FASN-dependent anticancer effect. Here we showed that leucine deprivation inhibited cell proliferation and induced apoptosis of MDA-MB-231 and MCF-7 breast cancer cells. In an in vivo tumor xenograft model, the leucine-free diet suppressed the growth of human breast cancer tumors and triggered widespread apoptosis of the cancer cells. Further study indicated that leucine deprivation decreased expression of lipogenic gene FASN in vitro and in vivo. Over-expression of FASN or supplementation of palmitic acid (the product of FASN action) blocked the effects of leucine deprivation on cell proliferation and apoptosis in vitro and in vivo. Moreover, leucine deprivation suppressed the FASN expression via regulating general control non-derepressible (GCN)2 and sterol regulatory element-binding protein 1C (SREBP1C). Taken together, our study represents proof of principle that anticancer effects can be obtained with strategies to deprive tumors of leucine via suppressing FASN expression, which provides important insights in prevention of breast cancer via metabolic intervention.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 11626